Jenni Björnulfson
Vorstandsvorsitzender bei LIDDS AB
Aktive Positionen von Jenni Björnulfson
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GHP SPECIALTY CARE AB (PUBL) | Corporate Officer/Principal | - | - |
| LIDDS AB | Vorstandsvorsitzender | 01.12.2023 | - |
| Finanzdirektor/CFO | 01.12.2021 | - | |
| Investor Relations Kontakt | 01.12.2021 | - | |
| The C Story AB | Direktor/Vorstandsmitglied | - | - |
Cinclus Pharma Holding AB
 Cinclus Pharma Holding AB BiotechnologyHealth Technology Cinclus Pharma Holding AB is a Swedish pharmaceutical company that focuses on developing clinical stage drug candidates for gastric acid related diseases. The company's drug candidate, linaprazan glurate, takes a new approach to provide improved management of GERD. Gastroesophageal reflux disease, or acid reflux, is a condition in which the content of the stomach regurgitates into the esophagus. The company was founded by pioneers in GERD treatment with extensive experience from Astra and Astra Zeneca. Christer Ahlberg has been the CEO of the company since 2021. | Finanzdirektor/CFO | - | - |
Karriereverlauf von Jenni Björnulfson
Ehemalige bekannte Positionen von Jenni Björnulfson
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Promore Pharma AB
 Promore Pharma AB BiotechnologyHealth Technology Promore Pharma AB is a biopharmaceutical company, which engages in the development of therapeutic peptides for the bioactive wound care market. The company was founded by Mona Ståhle and Johan Heilborn on January 29, 2003 and is headquartered in Solna, Sweden. | Finanzdirektor/CFO | 01.01.2016 | 25.08.2020 |
| Investor Relations Kontakt | 01.01.2016 | 25.08.2020 | |
| BIO VITOS PHARMA AB | Direktor/Vorstandsmitglied | 01.01.2016 | - |
| Independent Dir/Board Member | 01.01.2016 | - |
Ausbildung von Jenni Björnulfson
| Stockholm School of Economics | Graduate Degree |
| Karolinska Institutet | Undergraduate Degree |
Statistik
International
| Schweden | 9 |
Operativ
| Director of Finance/CFO | 3 |
| Director/Board Member | 2 |
| Investor Relations Contact | 2 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 3 |
| Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| BIO VITOS PHARMA AB | Health Technology |
| LIDDS AB | Health Technology |
 | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Promore Pharma AB
Promore Pharma AB BiotechnologyHealth Technology Promore Pharma AB is a biopharmaceutical company, which engages in the development of therapeutic peptides for the bioactive wound care market. The company was founded by Mona Ståhle and Johan Heilborn on January 29, 2003 and is headquartered in Solna, Sweden. | Health Technology |
GHP Specialty Care AB
 GHP Specialty Care AB Medical/Nursing ServicesHealth Services GHP Specialty Care AB engages in the provision of healthcare services. It operates business through the Nordic Region and Rest of the World segments. The Nordic Region segment conducts business within specialist care, such as spine surgery/spine care, orthopaedics, obesity surgery and diabetes care, gastroenterology, urology, gynaecology, general surgery, arrhythmia, maternal health care, plastic surgery, and specialist dentistry. The Rest of the World segment manages business in the field of diabetes care at one clinic in the United Arab Emirates. The company was founded by Per Båtelson and Johan Wachtmeister in 2006 and is headquartered in Göteborg, Sweden. | Health Services |
| The C Story AB |
- Börse
- Insiders
- Jenni Björnulfson
- Erfahrung
